You have 9 free searches left this month | for more free features.

Condition

Advanced Malignancy (1)

Advanced Solid Tumors (1)

Breast Cancer (1)

Metastasis (1)

Metastatic Triple-Negative Breast Cancer (1)

Neoplasm (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Memorial Sloan Kettering Cancer Center (1)

SynDevRx, Inc. (1)

Collaborator

SynDevRx, Inc. (1)

Intervention

sdx-7320 (2)

eribulin (1)

placebo (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

sdx-7320

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Breast Cancer, Metastatic Triple-Negative Breast Cancer Trial in United States (Eribulin, SDX-7320, Placebo)

Recruiting

Breast Cancer
Metastatic Triple-Negative Breast Cancer

Eribulin
+2 more

Basking Ridge, New Jersey
+6 more

Oct 4, 2022

Advanced Malignancy, Advanced Solid Tumors, Tumor Trial in Scottsdale, Los Angeles, Nashville (SDX-7320)

Completed

Advanced Malignancy
+3 more

SDX-7320

Scottsdale, Arizona
+2 more

Jan 22, 2020